跳至主要内容
临床试验/NCT01706016
NCT01706016已完成2 期

Local Treatment by Thermic Destruction of Primitive Breast Cancer. Phase II: Feasibility and Effectiveness, Standardization of Procedures.

Gustave Roussy, Cancer Campus, Grand Paris6 个研究点 分布在 1 个国家目标入组 16 人开始时间: 2012年10月9日最近更新:
适应症
干预措施

试验速览

阶段
2 期
状态
已完成
入组人数
16
试验地点
6
主要终点
Effectiveness of laser treatment

研究概览

简要总结

Demonstrate the effectiveness of laser in the treatment of cancerous lesions by determinating with histological analysis of the specimen the percentage of tumor cells remaining in the area treated by the laser

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Noninflammatory unilateral and unifocal breast cancer
  • Size </= 20mm (ultrasound measure)
  • Histological confirmation of cancer by biopsy grade status hormone and HER
  • Good delineation of the lesion on ultrasound.
  • Minimum distance of 5 mm between the tumor and the skin between the tumor and muscle.
  • Age between 18 and 80
  • ECOG performance status 0 or 1

排除标准

  • 未提供

研究组 & 干预措施

Patients with breast cancer smaller than 20mm

Experimental

干预措施: Thermic destruction of tissue by Laser using the Novilase device (Procedure)

结局指标

主要结局

Effectiveness of laser treatment

时间窗: 28 days after initial diagnosis

Destruction of the carcinoma will be assess by histological analysis of the specimen. If more than 10% of viables cancerous cells are remaining in the volume treated by laser, the procedure would be a fail

次要结局

  • Life quality(D-0 and before the surgery)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验

Local Treatment by Thermic Destruction of Primitive... | 临床试验